Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapy

  • Ann Oncol. 2021 Mar;32(3):295-297. doi: 10.1016/j.annonc.2020.11.018.
M Sznol  1 ,  I Melero  2
Affiliations
  • 1. Departments of Immunology and Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA. Electronic address: [email protected].
  • 2. Department of Immunology, CIMA and Clinica Universidad de Navarra, Pamplona, Spain; CIBERONC, Madrid, Spain.
PMID: 33307201 DOI: 10.1016/j.annonc.2020.11.018
Products